Investment in Britain’s vital life sciences sector is under threat due to a deteriorating commercial environment. Senior executives from major pharmaceutical companies, including Johnson & Johnson, are voicing concerns that
Investment in Britain’s vital life sciences sector is under threat due to a deteriorating commercial environment. Senior executives from major pharmaceutical companies, including Johnson & Johnson, are voicing concerns that
Britain’s largest pharmaceutical companies have raised urgent concerns over what they describe as an “excessive” NHS sales rebate, warning it is harming investment in an economically crucial sector. Industry leaders
Vital data accuracy is at risk in the UK due to the erasure of biological sex in official statistics, health records, and education data. A detailed review led by Professor
Oxford Medical Simulation, a UK-based virtual reality (VR) training company, has shifted its primary focus to the United States, citing bureaucratic obstacles within the NHS as a major hindrance to
The recent alignment of seven major planets over Britain coincided with promising developments in the field of genetics, particularly for UK-based Genomics, a genetic analytics firm spearheading a transformative approach
The takeover of Assura, one of the NHS’s largest landlords, appears to have moved a step closer after the American private equity firm KKR, in partnership with Stonepeak, raised its
A significant NHS property owner has suspended the construction of new medical facilities across the UK until governmental authorities agree to increase rental rates to economically sustainable levels. Primary Health
Assura, one of the UK’s largest owners of healthcare properties, has turned down a fourth takeover bid from US private equity giant KKR. The latest bid, submitted last week, valued
The NHS is seeking private sector funding to address its deteriorating infrastructure and record-breaking emergency department waiting times. Amanda Pritchard, the organisation’s chief executive, has urged ministers to adopt a
Chancellor Rachel Reeves recently visited Siemens Healthineers in Oxford to present a vision for revitalising Britain’s economic growth. Highlighting the nation’s potential in areas such as artificial intelligence and life
Spire Healthcare, the UK’s largest private healthcare provider, is witnessing unprecedented growth amid mounting NHS pressures. The FTSE 250-listed organisation has strategically positioned itself as a crucial partner in addressing
The head of Britain’s National Audit Office (NAO), Gareth Davies, has delivered a stark warning about the state of the nation’s public services, declaring them “not good enough and too
The dire state of UK government buildings has reached a critical point, with public services facing significant disruption due to deteriorating infrastructure, according to a stark warning from the National
British healthcare technology firm Cera has secured a landmark $150 million funding round, propelling the company to coveted unicorn status with a valuation exceeding $1 billion. The fundraising effort, combining
The British government is weighing a groundbreaking initiative that would permit private enterprises to monetise NHS patient data, marking a significant shift in healthcare data management. Labour leader Keir Starmer
The National Health Service faces unprecedented pressure as nine hospitals across England declare critical incidents, with patients experiencing wait times of up to two days in Accident and Emergency departments.






